Patterns of Relapse From a Phase III Study of Response-based Therapy for Intermediate-risk Hodgkin Lymphoma (AHOD0031): A Report from the Children’s Oncology Group

Reporter: Annemarie Fernandes, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 28 de octubre del 2012

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015